Blog - Page 4281 of 5383

ThursdayJul 10, 2008 1:15 pm

DoublingStocks.com Features MyECheck Inc. (MYEC.OB)

Michael Cohen from doublingstocks.com wrote last week that MyECheck was one of the strongest penny stocks. MyECheck Incorporated is a financial electronic transaction processor and provider of alternative payment solutions for Internet and mobile commerce. Cohen chose the stock because of the rapid growth MYEC has already experienced, and the potential for continued growth in both the near and distant future. The services offered by MyECheck are very tempting to businesses seeking immediate, secure payment from their customers. Earlier this month, MyECheck was granted a patent from the United States Patent & Trademark office for their proprietary technology capable of…

ThursdayJul 10, 2008 1:10 pm

Unigene Laboratories Inc. (UGNE.OB) CEO Featured in Globally Distributed Biotechnology Publication

According to the National Osteoporosis Foundation, osteoporosis afflicts approximately 10 million Americans; approximately 34 million individuals have low bone mass, putting them at risk for osteoporosis. Unigene Laboratories Inc. (OTCBB: UGNE) is a biopharmaceutical company engaged in the oral and nasal administration of large-market peptide drugs. Recognizing the growing worldwide osteoporosis market, Unigene focuses on developing PTH-based therapies and calcitonin, a product for the treatment of postmenopausal osteoporosis. Today the company announced Warren P. Levy, Ph.D., CEO and president of Unigene, recently contributed a byline story in two leading pharmaceutical publications. The article, titled “Focusing on the Task of Reinventing…

ThursdayJul 10, 2008 11:26 am

China Medicine Corporation (CHME) is “One to Watch”

China Medicine Corp., operating in the Wholesale Trade sector and established in 2005 as Lounsberry Holdings III, Inc., is a Delaware-registered company which in 2006 acquired Guangzhou Konzern Medicine Co., Ltd as its wholly owned subsidiary, and subsequently changed its name to China Medicine Corp. Operating in the People’s Republic of China, the company distributes both licensed, prescription pharmaceuticals and over-the-counter (OTC) remedies. Their OTC remedies include Chinese herbs and traditional Chinese medications made from these herbs, as well as nutritional and dietary supplements and medical instruments. The total distribution encompasses more than 2,000 products and product lines. China Medicine…

ThursdayJul 10, 2008 10:59 am

Dutton Associates Featured Company: Pluristem Therapeutics, Inc. (PSTI)

Pluristem Therapeutics, Inc. (NASDAQ: PSTI) is a regenerative biotherapeutics corporation focused on commercializing non-personalized (allogeneic) stem cell therapy products for the treatment of severe degenerative, malignant, and autoimmune disorders. The company is dedicated to developing a platform designed to create stem cell-based therapeutic products that can treat severe blood, cardiovascular, autoimmune, and other disorders. The company is currently developing the PluriX™ 3D Bioreactor System, which is designed to create an artificial physiological environment where mesenchymal stem cells can expand in three dimensions and reproduce without the use of exogenous biologics or pharmacological products. This new method is superior to the…

ThursdayJul 10, 2008 10:39 am

Dutton Associates Featured Company: Pressure BioSciences, Inc. (PBIO)

Pressure BioSciences, Inc. (PBIO) is focused on developing products based on its proprietary pressure cycling technology (PCT) for life-sciences applications. The innovative technology utilizes hydrostatic pressure, which cycles between ambient and ultra-high levels, to rapidly and proficiently disrupt cell membranes/tissues to remove nucleic acids, proteins, and small molecules from plant and animal materials. The PCT technology has a broad range of possible applications in genomics and proteomics, in addition to drug discovery, pathogen inactivation, food safety, immunodiagnostics, and DNA sequencing. Currently, the PCT System consists of a top-of-the-line instrument and disposable PULSE sample processing tubes. Pressure BioSciences plans to develop…

ThursdayJul 10, 2008 10:11 am

Emcore Corp. (EMKR) Announces Supply Agreements Totaling $29M

The sales announcement of 2 solar photovoltaic receivers is exciting for Emcore Corp., ensuring its growth in the photovoltaic segment of its business. The sale is important for Emcore, which did very well in 2006 with a net income of $54M. In 2007, cost of revenue went up, as did SG&A, leading to a net income loss of -$58M. This sale may be its return to profitability. Emcore Solar Photovoltaic technologies convert optical light into electrical energy, enabling power generation, while Emcore fiber optics technologies convert electrical energy into optical signals, enabling high-speed communication infrastructures. Emcore builds turnkey concentrator photovoltaic…

ThursdayJul 10, 2008 10:07 am

ULURU Inc. (ULU) to Acquire Bio Med Sciences, Inc for $10 Million

ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and hydrogel nanoparticle aggregate technology. ULURU Inc. has developed a patented, water-erodable pharmaceutical carrier device. The multi-layered device is applied to mucosal surfaces, and delivers medications to treat specific localized diseases/disorders. This OraDisc™ technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy…

ThursdayJul 10, 2008 10:01 am

Westwood One, Inc. (WON) Closes Sale of Preferred Stock to Gores Radio Holdings, LLC

Westwood One, Inc. (WON) supplies radio and television stations with information services and programming. The company provides traffic reporting services and the nation’s largest radio network, producing and distributing national news, sports, talk, music and special event programs to its affiliate stations. The company’s main source of revenue is selling commercial airtime to advertisers through one of its two operating divisions: Metro/Shadow, which encompasses Metro Networks and Shadow Broadcast Services, and the Westwood One Network Division. Last month the company closed the sale of $75M of a newly created series of preferred stock, 7.05% Series A convertible preferred stock, to…

ThursdayJul 10, 2008 9:15 am

Schawk, Inc. (SGK) Establishes New Brand Identity; Rebrands its Direct Marketing Agency

Schawk, Inc. (SGK), established by Clarence Schawk, a former World War II U.S. marine, delivers a broad range of digital pre-media graphic services through 169 locations in 13 countries across North America, Europe, Asia and Australia. Schawk, headquartered in Des Plaines, Illinois, began in Chicago under the name of Schawk Litho Plate, and through numerous mergers and acquisitions with prepress firms in the Midwest, the company established a corporate name in the mid-1980s. Schawk designs, creates and manages image and text for reproduction to exact specifications for a variety of media, including packing for consumer products, point-of-sale displays and other…

ThursdayJul 10, 2008 8:30 am

SGX Pharmaceuticals, Inc. (SGXP) Submits FDA Investigational New Drug Application

SGX Pharmaceuticals is a biopharmaceutical company which focuses mainly on the development and commercialization of new oncological, or cancer therapies. Yesterday, the company announced its submission of an Investigational New Drug (IND) application for FDA approval. The drug is known as SGX393, and is currently undergoing clinical testing of its ability to treat two forms of CML, or, chronic myelogenous leukemia (a type of cancer in which white blood cells belonging to the myeloid line of cells are over-produced in the bone marrow). At present, the standard treatment for CML is a product known as Gleevec®, however there have been…

Site Search

Company Search